{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T13:52:35Z","timestamp":1724421155041},"reference-count":12,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.8781-16","type":"journal-article","created":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T18:15:19Z","timestamp":1505412919000},"page":"2759-2763","source":"Crossref","is-referenced-by-count":5,"title":["Development of Epstein-Barr Virus-related Primary Diffuse Large B-cell Lymphoma of the Central Nervous System in a Patient with Peripheral T-cell Lymphoma, Not Otherwise Specified after Mogamulizumab Treatment"],"prefix":"10.2169","volume":"56","author":[{"given":"Hiroaki","family":"Tanaka","sequence":"first","affiliation":[{"name":"Department of Hematology, Asahi General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanako","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Asahi General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasumasa","family":"Sugita","sequence":"additional","affiliation":[{"name":"Department of Hematology, Asahi General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Asahi General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsunari","family":"Kiko","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Asahi General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Mochida","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Asahi General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Asahi General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Ishida T, Joh T, Uike N, et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. J Clin Oncol 30: 837-842, 2012."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ogura M, Ishida T, Hatake K, et al. Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma. J Clin Oncol 32: 1157-1163, 2014.","DOI":"10.1200\/JCO.2013.52.0924"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10: 942-949, 2004.","DOI":"10.1038\/nm1093"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ito A, Ishida T, Yano H, et al. Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD\/Shi-scid, IL-2Rgamma(null) mouse model. Cancer Immunol Immunother 58: 1195-1206, 2009.","DOI":"10.1007\/s00262-008-0632-0"},{"key":"5","unstructured":"5. Mahadevan A, Rao CR, Shanmugham M, Shankar SK. Primary central nervous system diffuse large B-cell lymphoma in the immunocompetent: Immunophenotypic subtypes and Epstein-Barr virus association. J Neurosci Rural Pract 6: 8-14, 2015."},{"key":"6","unstructured":"6. Kluin PM, Deckert M, Feery JA. Primary diffuse large B-cell lymphoma of the CNS. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Swerdlow SH, Campo E, Harris NL, Eds. IARC, Lyon, 2008: 240-241."},{"key":"7","unstructured":"7. Chang KL, Flaris N, Hickey WF, Johnson RM, Meyer JS, Weiss LM. Brain lymphomas of immunocompetent and immunocompromised patients: study of the association with Epstein-Barr virus. Mod Pathol 6: 427-432, 1993."},{"key":"8","unstructured":"8. Ishida T, Jo T, Takemoto S, et al. Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study. Br J Haematol 169: 672-682, 2015."},{"key":"9","unstructured":"9. Ohyama Y, Kumode T, Eguchi G, et al. Induction of molecular remission by using anti-CC-chemokine receptor 4 (anti-CCR4) antibodies for adult T cell leukemia: a risk of opportunistic infection after treatment with anti-CCR4 antibodies. Ann Hematol 93: 169-171, 2014."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Totani H, Kusumoto S, Ishida T, et al. Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia-lymphoma patients with resolved HBV infection following systemic chemotherapy. Int J Hematol 101: 398-404, 2015.","DOI":"10.1007\/s12185-015-1750-z"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Tamaki K, Kinjo T, Aoyama H, et al. Fatal pneumonia and viremia due to human parainfluenza virus type 1 in a patient with adult T-cell leukemia lymphoma treated with mogamulizumab. J Infect Chemother 21: 820-823, 2015.","DOI":"10.1016\/j.jiac.2015.07.001"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ishii Y, Itabashi M, Numata M, et al. Cytomegalovirus pneumonia after anti-CC-chemokine receptor 4 monoclonal antibody (mogamulizumab) therapy in an angioimmunoblastic T-cell lymphoma patient. Intern Med 55: 673-675, 2016.","DOI":"10.2169\/internalmedicine.55.5644"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/20\/56_8781-16\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T10:00:13Z","timestamp":1570096813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/20\/56_8781-16\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":12,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8781-16","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}